Keyphrases
Nanoparticle Vaccine
69%
Depot
69%
Tumor Microenvironment
69%
Sustained Release
69%
In Situ
69%
Antitumor Immune Response
69%
Anticancer
69%
Toll-like Receptor 7 (TLR7)
69%
Sustained Delivery
34%
In Vitro Tumor Models
34%
Therapeutic Performance
34%
Solid Cancer
34%
Heterogeneous Solids
34%
Cancer Tissue
34%
Activated State
34%
Anticancer Immune Response
34%
Toll-like
34%
Imaging Contrast
34%
Immune Response
34%
Transforming Growth Factor-β
34%
Immunoreactivity
34%
Immunosuppressive Microenvironment
34%
Growth Factor Inhibitors
34%
Tolerability
34%
Immune Stimulation
34%
Thin Needle
34%
Immune Activation
34%
Tumor-draining Lymph Nodes
34%
Sustained Drug Release
34%
High-payload
34%
Female Mice
34%
Dual Drug
34%
Immune Cells
34%
Hydrophobic Ions
23%
Particle Uptake
17%
Vaccine Particles
17%
Particle Internalization
8%
Multiple Routes
8%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Toll Like Receptor 7
76%
Excipient
69%
Epitope
69%
Solid Lipid Nanoparticle
69%
Sodium Chloride
69%
Base
69%
Tumor Microenvironment
69%
Sustained Release
69%
Vaccination Policy
38%
Malignant Neoplasm
38%
Disaccharide
34%
Counterion
34%
Trisaccharide
34%
Tolerability
23%
Cancer Growth Factor
23%
Drug Release
23%
Immunosuppressive Agent
23%
Tumor Model
23%
Ovalbumin
15%
Murine
7%
Cancer Vaccine
7%
Immunotherapy
7%
Melanoma
7%
Microparticle
7%
Chemotherapy
7%
Drug Delivery System
7%
T Lymphocyte Receptor
7%
Therapeutic Vaccine
7%
Monotherapy
7%
Metastasis
7%
Tumor Growth
7%
COVID-19 Vaccine
7%
Nanoparticle
7%
CD8 Antigen
7%
Immunology and Microbiology
Vaccine Efficacy
69%
Epitope
69%
T Cell
37%
Vaccination Policy
31%
Dendritic Cell
18%
Toll-Like Receptor
17%
Immune Response
12%
Antigen Presentation
12%
CD4
6%
COVID-19
6%
Agonist
6%
CD8
6%
Murine
6%
Cell Infiltration
6%
Peptide Synthesis
6%
Cancer Vaccine
6%
Cancer Immunotherapy
6%
Antigen-Presenting Cell
6%
Internalization
6%
Syngenic
6%
TLR7
6%
Solid
6%
Surface Property
6%
T Cell Receptor
6%
